4//SEC Filing
WINDSOR JAMES BRIAN 4
Accession 0001213900-20-041813
CIK 0001733413other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 4:30 PM ET
Size
8.8 KB
Accession
0001213900-20-041813
Insider Transaction Report
Form 4
WINDSOR JAMES BRIAN
DirectorChief Science Officer
Transactions
- Exercise/Conversion
Stock Options (Right to Buy)
2020-12-07−25,000→ 134,429 totalExercise: $2.50From: 2019-09-26Exp: 2028-09-26→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2020-12-07$2.50/sh+25,000$62,500→ 30,000 total - Sale
Common Stock
2020-12-07$15.80/sh−25,000$395,000→ 5,000 total
Footnotes (2)
- [F1]The transactions reported by this Form 4 reflect the Reporting Person's exercise of options to purchase common shares pursuant to Rule 16b-3 under the Securities Exchange Act of 1934 and the Reporting Person's concurrent sale of the common shares acquired upon the exercise of the options.
- [F2]18,003 shares of common stock vested on September 26, 2019 and the remainder of the shares vested at an approximate rate of 4,500 every three months thereafter.
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
Related Parties
1- filerCIK 0001790933
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 4:30 PM ET
- Size
- 8.8 KB